▶ 調査レポート

核酸マルチプレックスアッセイのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Nucleic Acid Multiplex Assays Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。核酸マルチプレックスアッセイのグローバル市場インサイト・予測(~2028年) / Global Nucleic Acid Multiplex Assays Market Insights, Forecast to 2028 / QY2203B08204資料のイメージです。• レポートコード:QY2203B08204
• 出版社/出版日:QYResearch / 2022年3月
• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥686,000 (USD4,900)▷ お問い合わせ
  Multi User¥1,029,000 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,372,000 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の核酸マルチプレックスアッセイの市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に核酸マルチプレックスアッセイの世界市場のxxx%を占める「プレーナー核酸アッセイ」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「製薬・バイオ企業」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の核酸マルチプレックスアッセイの市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの核酸マルチプレックスアッセイ市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの核酸マルチプレックスアッセイ市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

核酸マルチプレックスアッセイのグローバル主要メーカーには、Abcam、Becton、Dickinson and Company、Merck KGaA、Agilent Technologies、Bio-Techne、Shimadzu Biotech、Thermo Fisher Scientific、Bio-Rad Laboratories、Qiagen、Luminex Corporationなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

核酸マルチプレックスアッセイ市場は、種類と用途によって区分されます。世界の核酸マルチプレックスアッセイ市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
プレーナー核酸アッセイ、ビーズベース核酸アッセイ、その他核酸アッセイ

【用途別セグメント】
製薬・バイオ企業、病院・研究機関、研究所、その他エンドユーザー

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 核酸マルチプレックスアッセイ製品概要
- 種類別市場(プレーナー核酸アッセイ、ビーズベース核酸アッセイ、その他核酸アッセイ)
- 用途別市場(製薬・バイオ企業、病院・研究機関、研究所、その他エンドユーザー)
- 調査の目的
・エグゼクティブサマリー
- 世界の核酸マルチプレックスアッセイ販売量予測2017-2028
- 世界の核酸マルチプレックスアッセイ売上予測2017-2028
- 核酸マルチプレックスアッセイの地域別販売量
- 核酸マルチプレックスアッセイの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別核酸マルチプレックスアッセイ販売量
- 主要メーカー別核酸マルチプレックスアッセイ売上
- 主要メーカー別核酸マルチプレックスアッセイ価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(プレーナー核酸アッセイ、ビーズベース核酸アッセイ、その他核酸アッセイ)
- 核酸マルチプレックスアッセイの種類別販売量
- 核酸マルチプレックスアッセイの種類別売上
- 核酸マルチプレックスアッセイの種類別価格
・用途別市場規模(製薬・バイオ企業、病院・研究機関、研究所、その他エンドユーザー)
- 核酸マルチプレックスアッセイの用途別販売量
- 核酸マルチプレックスアッセイの用途別売上
- 核酸マルチプレックスアッセイの用途別価格
・北米市場
- 北米の核酸マルチプレックスアッセイ市場規模(種類別、用途別)
- 主要国別の核酸マルチプレックスアッセイ市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの核酸マルチプレックスアッセイ市場規模(種類別、用途別)
- 主要国別の核酸マルチプレックスアッセイ市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の核酸マルチプレックスアッセイ市場規模(種類別、用途別)
- 主要国別の核酸マルチプレックスアッセイ市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の核酸マルチプレックスアッセイ市場規模(種類別、用途別)
- 主要国別の核酸マルチプレックスアッセイ市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの核酸マルチプレックスアッセイ市場規模(種類別、用途別)
- 主要国別の核酸マルチプレックスアッセイ市場規模(トルコ、サウジアラビア)
・企業情報
Abcam、Becton、Dickinson and Company、Merck KGaA、Agilent Technologies、Bio-Techne、Shimadzu Biotech、Thermo Fisher Scientific、Bio-Rad Laboratories、Qiagen、Luminex Corporation
・産業チェーン及び販売チャネル分析
- 核酸マルチプレックスアッセイの産業チェーン分析
- 核酸マルチプレックスアッセイの原材料
- 核酸マルチプレックスアッセイの生産プロセス
- 核酸マルチプレックスアッセイの販売及びマーケティング
- 核酸マルチプレックスアッセイの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 核酸マルチプレックスアッセイの産業動向
- 核酸マルチプレックスアッセイのマーケットドライバー
- 核酸マルチプレックスアッセイの課題
- 核酸マルチプレックスアッセイの阻害要因
・主な調査結果

Multiplex Nucleic Acid Assay for Identification of Microorganisms and Resistance Markers from Positive Blood Cultures – Class II Special Controls Guideline for Industry and Food and Drug Administration Staff
Market Analysis and Insights: Global Nucleic Acid Multiplex Assays Market
The global Nucleic Acid Multiplex Assays market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Planar Nucleic Acid Assays accounting for % of the Nucleic Acid Multiplex Assays global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pharmaceutical & Biotechnology Companies segment is altered to an % CAGR throughout this forecast period.
China Nucleic Acid Multiplex Assays market size is valued at US$ million in 2021, while the North America and Europe Nucleic Acid Multiplex Assays are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Nucleic Acid Multiplex Assays landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nucleic Acid Multiplex Assays market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nucleic Acid Multiplex Assays market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nucleic Acid Multiplex Assays market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nucleic Acid Multiplex Assays market.
Global Nucleic Acid Multiplex Assays Scope and Market Size
Nucleic Acid Multiplex Assays market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Nucleic Acid Multiplex Assays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Planar Nucleic Acid Assays
Bead-Based Nucleic Acid Assays
Other Nucleic Acid Assays
Segment by Application
Pharmaceutical & Biotechnology Companies
Hospitals & Research Institutes
Reference Laboratories
Other End Users
By Company
Abcam
Becton
Dickinson and Company
Merck KGaA
Agilent Technologies
Bio-Techne
Shimadzu Biotech
Thermo Fisher Scientific
Bio-Rad Laboratories
Qiagen
Luminex Corporation
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

レポート目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Planar Nucleic Acid Assays
1.2.3 Bead-Based Nucleic Acid Assays
1.2.4 Other Nucleic Acid Assays
1.3 Market by Application
1.3.1 Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 Hospitals & Research Institutes
1.3.4 Reference Laboratories
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nucleic Acid Multiplex Assays Market Perspective (2017-2028)
2.2 Nucleic Acid Multiplex Assays Growth Trends by Region
2.2.1 Nucleic Acid Multiplex Assays Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Nucleic Acid Multiplex Assays Historic Market Size by Region (2017-2022)
2.2.3 Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2023-2028)
2.3 Nucleic Acid Multiplex Assays Market Dynamics
2.3.1 Nucleic Acid Multiplex Assays Industry Trends
2.3.2 Nucleic Acid Multiplex Assays Market Drivers
2.3.3 Nucleic Acid Multiplex Assays Market Challenges
2.3.4 Nucleic Acid Multiplex Assays Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue
3.1.1 Global Top Nucleic Acid Multiplex Assays Players by Revenue (2017-2022)
3.1.2 Global Nucleic Acid Multiplex Assays Revenue Market Share by Players (2017-2022)
3.2 Global Nucleic Acid Multiplex Assays Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Nucleic Acid Multiplex Assays Revenue
3.4 Global Nucleic Acid Multiplex Assays Market Concentration Ratio
3.4.1 Global Nucleic Acid Multiplex Assays Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nucleic Acid Multiplex Assays Revenue in 2021
3.5 Nucleic Acid Multiplex Assays Key Players Head office and Area Served
3.6 Key Players Nucleic Acid Multiplex Assays Product Solution and Service
3.7 Date of Enter into Nucleic Acid Multiplex Assays Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nucleic Acid Multiplex Assays Breakdown Data by Type
4.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Type (2017-2022)
4.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2023-2028)
5 Nucleic Acid Multiplex Assays Breakdown Data by Application
5.1 Global Nucleic Acid Multiplex Assays Historic Market Size by Application (2017-2022)
5.2 Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Nucleic Acid Multiplex Assays Market Size (2017-2028)
6.2 North America Nucleic Acid Multiplex Assays Market Size by Type
6.2.1 North America Nucleic Acid Multiplex Assays Market Size by Type (2017-2022)
6.2.2 North America Nucleic Acid Multiplex Assays Market Size by Type (2023-2028)
6.2.3 North America Nucleic Acid Multiplex Assays Market Share by Type (2017-2028)
6.3 North America Nucleic Acid Multiplex Assays Market Size by Application
6.3.1 North America Nucleic Acid Multiplex Assays Market Size by Application (2017-2022)
6.3.2 North America Nucleic Acid Multiplex Assays Market Size by Application (2023-2028)
6.3.3 North America Nucleic Acid Multiplex Assays Market Share by Application (2017-2028)
6.4 North America Nucleic Acid Multiplex Assays Market Size by Country
6.4.1 North America Nucleic Acid Multiplex Assays Market Size by Country (2017-2022)
6.4.2 North America Nucleic Acid Multiplex Assays Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Nucleic Acid Multiplex Assays Market Size (2017-2028)
7.2 Europe Nucleic Acid Multiplex Assays Market Size by Type
7.2.1 Europe Nucleic Acid Multiplex Assays Market Size by Type (2017-2022)
7.2.2 Europe Nucleic Acid Multiplex Assays Market Size by Type (2023-2028)
7.2.3 Europe Nucleic Acid Multiplex Assays Market Share by Type (2017-2028)
7.3 Europe Nucleic Acid Multiplex Assays Market Size by Application
7.3.1 Europe Nucleic Acid Multiplex Assays Market Size by Application (2017-2022)
7.3.2 Europe Nucleic Acid Multiplex Assays Market Size by Application (2023-2028)
7.3.3 Europe Nucleic Acid Multiplex Assays Market Share by Application (2017-2028)
7.4 Europe Nucleic Acid Multiplex Assays Market Size by Country
7.4.1 Europe Nucleic Acid Multiplex Assays Market Size by Country (2017-2022)
7.4.2 Europe Nucleic Acid Multiplex Assays Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size (2017-2028)
8.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Type
8.2.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Share by Type (2017-2028)
8.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Application
8.3.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Nucleic Acid Multiplex Assays Market Share by Application (2017-2028)
8.4 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region
8.4.1 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Nucleic Acid Multiplex Assays Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nucleic Acid Multiplex Assays Market Size (2017-2028)
9.2 Latin America Nucleic Acid Multiplex Assays Market Size by Type
9.2.1 Latin America Nucleic Acid Multiplex Assays Market Size by Type (2017-2022)
9.2.2 Latin America Nucleic Acid Multiplex Assays Market Size by Type (2023-2028)
9.2.3 Latin America Nucleic Acid Multiplex Assays Market Share by Type (2017-2028)
9.3 Latin America Nucleic Acid Multiplex Assays Market Size by Application
9.3.1 Latin America Nucleic Acid Multiplex Assays Market Size by Application (2017-2022)
9.3.2 Latin America Nucleic Acid Multiplex Assays Market Size by Application (2023-2028)
9.3.3 Latin America Nucleic Acid Multiplex Assays Market Share by Application (2017-2028)
9.4 Latin America Nucleic Acid Multiplex Assays Market Size by Country
9.4.1 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2017-2022)
9.4.2 Latin America Nucleic Acid Multiplex Assays Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size (2017-2028)
10.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Type
10.2.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Share by Type (2017-2028)
10.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Application
10.3.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Nucleic Acid Multiplex Assays Market Share by Application (2017-2028)
10.4 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country
10.4.1 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Nucleic Acid Multiplex Assays Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Details
11.1.2 Abcam Business Overview
11.1.3 Abcam Nucleic Acid Multiplex Assays Introduction
11.1.4 Abcam Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.1.5 Abcam Recent Developments
11.2 Becton
11.2.1 Becton Company Details
11.2.2 Becton Business Overview
11.2.3 Becton Nucleic Acid Multiplex Assays Introduction
11.2.4 Becton Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.2.5 Becton Recent Developments
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Details
11.3.2 Dickinson and Company Business Overview
11.3.3 Dickinson and Company Nucleic Acid Multiplex Assays Introduction
11.3.4 Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.3.5 Dickinson and Company Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Details
11.4.2 Merck KGaA Business Overview
11.4.3 Merck KGaA Nucleic Acid Multiplex Assays Introduction
11.4.4 Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.4.5 Merck KGaA Recent Developments
11.5 Agilent Technologies
11.5.1 Agilent Technologies Company Details
11.5.2 Agilent Technologies Business Overview
11.5.3 Agilent Technologies Nucleic Acid Multiplex Assays Introduction
11.5.4 Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.5.5 Agilent Technologies Recent Developments
11.6 Bio-Techne
11.6.1 Bio-Techne Company Details
11.6.2 Bio-Techne Business Overview
11.6.3 Bio-Techne Nucleic Acid Multiplex Assays Introduction
11.6.4 Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.6.5 Bio-Techne Recent Developments
11.7 Shimadzu Biotech
11.7.1 Shimadzu Biotech Company Details
11.7.2 Shimadzu Biotech Business Overview
11.7.3 Shimadzu Biotech Nucleic Acid Multiplex Assays Introduction
11.7.4 Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.7.5 Shimadzu Biotech Recent Developments
11.8 Thermo Fisher Scientific
11.8.1 Thermo Fisher Scientific Company Details
11.8.2 Thermo Fisher Scientific Business Overview
11.8.3 Thermo Fisher Scientific Nucleic Acid Multiplex Assays Introduction
11.8.4 Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.8.5 Thermo Fisher Scientific Recent Developments
11.9 Bio-Rad Laboratories
11.9.1 Bio-Rad Laboratories Company Details
11.9.2 Bio-Rad Laboratories Business Overview
11.9.3 Bio-Rad Laboratories Nucleic Acid Multiplex Assays Introduction
11.9.4 Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.9.5 Bio-Rad Laboratories Recent Developments
11.10 Qiagen
11.10.1 Qiagen Company Details
11.10.2 Qiagen Business Overview
11.10.3 Qiagen Nucleic Acid Multiplex Assays Introduction
11.10.4 Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.10.5 Qiagen Recent Developments
11.11 Luminex Corporation
11.11.1 Luminex Corporation Company Details
11.11.2 Luminex Corporation Business Overview
11.11.3 Luminex Corporation Nucleic Acid Multiplex Assays Introduction
11.11.4 Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2017-2022)
11.11.5 Luminex Corporation Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Planar Nucleic Acid Assays
Table 3. Key Players of Bead-Based Nucleic Acid Assays
Table 4. Key Players of Other Nucleic Acid Assays
Table 5. Global Nucleic Acid Multiplex Assays Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 6. Global Nucleic Acid Multiplex Assays Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Nucleic Acid Multiplex Assays Market Size by Region (2017-2022) & (US$ Million)
Table 8. Global Nucleic Acid Multiplex Assays Market Share by Region (2017-2022)
Table 9. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 10. Global Nucleic Acid Multiplex Assays Market Share by Region (2023-2028)
Table 11. Nucleic Acid Multiplex Assays Market Trends
Table 12. Nucleic Acid Multiplex Assays Market Drivers
Table 13. Nucleic Acid Multiplex Assays Market Challenges
Table 14. Nucleic Acid Multiplex Assays Market Restraints
Table 15. Global Nucleic Acid Multiplex Assays Revenue by Players (2017-2022) & (US$ Million)
Table 16. Global Nucleic Acid Multiplex Assays Revenue Share by Players (2017-2022)
Table 17. Global Top Nucleic Acid Multiplex Assays by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2021)
Table 18. Ranking of Global Top Nucleic Acid Multiplex Assays Companies by Revenue (US$ Million) in 2021
Table 19. Global 5 Largest Players Market Share by Nucleic Acid Multiplex Assays Revenue (CR5 and HHI) & (2017-2022)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nucleic Acid Multiplex Assays Product Solution and Service
Table 22. Date of Enter into Nucleic Acid Multiplex Assays Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 25. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2017-2022)
Table 26. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 27. Global Nucleic Acid Multiplex Assays Revenue Market Share by Type (2023-2028)
Table 28. Global Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 29. Global Nucleic Acid Multiplex Assays Revenue Share by Application (2017-2022)
Table 30. Global Nucleic Acid Multiplex Assays Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 31. Global Nucleic Acid Multiplex Assays Revenue Share by Application (2023-2028)
Table 32. North America Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 33. North America Nucleic Acid Multiplex Assays Market Size by Type (2023-2028) & (US$ Million)
Table 34. North America Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 35. North America Nucleic Acid Multiplex Assays Market Size by Application (2023-2028) & (US$ Million)
Table 36. North America Nucleic Acid Multiplex Assays Market Size by Country (2017-2022) & (US$ Million)
Table 37. North America Nucleic Acid Multiplex Assays Market Size by Country (2023-2028) & (US$ Million)
Table 38. Europe Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 39. Europe Nucleic Acid Multiplex Assays Market Size by Type (2023-2028) & (US$ Million)
Table 40. Europe Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 41. Europe Nucleic Acid Multiplex Assays Market Size by Application (2023-2028) & (US$ Million)
Table 42. Europe Nucleic Acid Multiplex Assays Market Size by Country (2017-2022) & (US$ Million)
Table 43. Europe Nucleic Acid Multiplex Assays Market Size by Country (2023-2028) & (US$ Million)
Table 44. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 45. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Type (2023-2028) & (US$ Million)
Table 46. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 47. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Application (2023-2028) & (US$ Million)
Table 48. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Region (2017-2022) & (US$ Million)
Table 49. Asia Pacific Nucleic Acid Multiplex Assays Market Size by Region (2023-2028) & (US$ Million)
Table 50. Latin America Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 51. Latin America Nucleic Acid Multiplex Assays Market Size by Type (2023-2028) & (US$ Million)
Table 52. Latin America Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 53. Latin America Nucleic Acid Multiplex Assays Market Size by Application (2023-2028) & (US$ Million)
Table 54. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2017-2022) & (US$ Million)
Table 55. Latin America Nucleic Acid Multiplex Assays Market Size by Country (2023-2028) & (US$ Million)
Table 56. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Type (2017-2022) & (US$ Million)
Table 57. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Type (2023-2028) & (US$ Million)
Table 58. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Application (2017-2022) & (US$ Million)
Table 59. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Application (2023-2028) & (US$ Million)
Table 60. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Country (2017-2022) & (US$ Million)
Table 61. Middle East and Africa Nucleic Acid Multiplex Assays Market Size by Country (2023-2028) & (US$ Million)
Table 62. Abcam Company Details
Table 63. Abcam Business Overview
Table 64. Abcam Nucleic Acid Multiplex Assays Product
Table 65. Abcam Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 66. Abcam Recent Developments
Table 67. Becton Company Details
Table 68. Becton Business Overview
Table 69. Becton Nucleic Acid Multiplex Assays Product
Table 70. Becton Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 71. Becton Recent Developments
Table 72. Dickinson and Company Company Details
Table 73. Dickinson and Company Business Overview
Table 74. Dickinson and Company Nucleic Acid Multiplex Assays Product
Table 75. Dickinson and Company Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 76. Dickinson and Company Recent Developments
Table 77. Merck KGaA Company Details
Table 78. Merck KGaA Business Overview
Table 79. Merck KGaA Nucleic Acid Multiplex Assays Product
Table 80. Merck KGaA Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 81. Merck KGaA Recent Developments
Table 82. Agilent Technologies Company Details
Table 83. Agilent Technologies Business Overview
Table 84. Agilent Technologies Nucleic Acid Multiplex Assays Product
Table 85. Agilent Technologies Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 86. Agilent Technologies Recent Developments
Table 87. Bio-Techne Company Details
Table 88. Bio-Techne Business Overview
Table 89. Bio-Techne Nucleic Acid Multiplex Assays Product
Table 90. Bio-Techne Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 91. Bio-Techne Recent Developments
Table 92. Shimadzu Biotech Company Details
Table 93. Shimadzu Biotech Business Overview
Table 94. Shimadzu Biotech Nucleic Acid Multiplex Assays Product
Table 95. Shimadzu Biotech Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 96. Shimadzu Biotech Recent Developments
Table 97. Thermo Fisher Scientific Company Details
Table 98. Thermo Fisher Scientific Business Overview
Table 99. Thermo Fisher Scientific Nucleic Acid Multiplex Assays Product
Table 100. Thermo Fisher Scientific Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 101. Thermo Fisher Scientific Recent Developments
Table 102. Bio-Rad Laboratories Company Details
Table 103. Bio-Rad Laboratories Business Overview
Table 104. Bio-Rad Laboratories Nucleic Acid Multiplex Assays Product
Table 105. Bio-Rad Laboratories Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 106. Bio-Rad Laboratories Recent Developments
Table 107. Qiagen Company Details
Table 108. Qiagen Business Overview
Table 109. Qiagen Nucleic Acid Multiplex Assays Product
Table 110. Qiagen Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 111. Qiagen Recent Developments
Table 112. Luminex Corporation Company Details
Table 113. Luminex Corporation Business Overview
Table 114. Luminex Corporation Nucleic Acid Multiplex Assays Product
Table 115. Luminex Corporation Revenue in Nucleic Acid Multiplex Assays Business (2017-2022) & (US$ Million)
Table 116. Luminex Corporation Recent Developments
Table 117. Research Programs/Design for This Report
Table 118. Key Data Information from Secondary Sources
Table 119. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nucleic Acid Multiplex Assays Market Share by Type: 2021 VS 2028
Figure 2. Planar Nucleic Acid Assays Features
Figure 3. Bead-Based Nucleic Acid Assays Features
Figure 4. Other Nucleic Acid Assays Features
Figure 5. Global Nucleic Acid Multiplex Assays Market Share by Application: 2021 VS 2028
Figure 6. Pharmaceutical & Biotechnology Companies Case Studies
Figure 7. Hospitals & Research Institutes Case Studies
Figure 8. Reference Laboratories Case Studies
Figure 9. Other End Users Case Studies
Figure 10. Nucleic Acid Multiplex Assays Report Years Considered
Figure 11. Global Nucleic Acid Multiplex Assays Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 12. Global Nucleic Acid Multiplex Assays Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Nucleic Acid Multiplex Assays Market Share by Region: 2021 VS 2028
Figure 14. Global Nucleic Acid Multiplex Assays Market Share by Players in 2021
Figure 15. Global Top Nucleic Acid Multiplex Assays Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nucleic Acid Multiplex Assays as of 2021)
Figure 16. The Top 10 and 5 Players Market Share by Nucleic Acid Multiplex Assays Revenue in 2021
Figure 17. North America Nucleic Acid Multiplex Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 18. North America Nucleic Acid Multiplex Assays Market Size Market Share by Type (2017-2028)
Figure 19. North America Nucleic Acid Multiplex Assays Market Size Market Share by Application (2017-2028)
Figure 20. North America Nucleic Acid Multiplex Assays Market Size Share by Country (2017-2028)
Figure 21. United States Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Canada Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Nucleic Acid Multiplex Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 24. Europe Nucleic Acid Multiplex Assays Market Size Market Share by Type (2017-2028)
Figure 25. Europe Nucleic Acid Multiplex Assays Market Size Market Share by Application (2017-2028)
Figure 26. Europe Nucleic Acid Multiplex Assays Market Size Share by Country (2017-2028)
Figure 27. Germany Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. France Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. U.K. Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Italy Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Russia Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Nordic Countries Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Nucleic Acid Multiplex Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 34. Asia Pacific Nucleic Acid Multiplex Assays Market Size Market Share by Type (2017-2028)
Figure 35. Asia Pacific Nucleic Acid Multiplex Assays Market Size Market Share by Application (2017-2028)
Figure 36. Asia Pacific Nucleic Acid Multiplex Assays Market Size Share by Region (2017-2028)
Figure 37. China Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Japan Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. South Korea Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Southeast Asia Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. India Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Australia Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 43. Latin America Nucleic Acid Multiplex Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 44. Latin America Nucleic Acid Multiplex Assays Market Size Market Share by Type (2017-2028)
Figure 45. Latin America Nucleic Acid Multiplex Assays Market Size Market Share by Application (2017-2028)
Figure 46. Latin America Nucleic Acid Multiplex Assays Market Size Share by Country (2017-2028)
Figure 47. Mexico Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Brazil Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Middle East & Africa Nucleic Acid Multiplex Assays Market Size YoY (2017-2028) & (US$ Million)
Figure 50. Middle East and Africa Nucleic Acid Multiplex Assays Market Size Market Share by Type (2017-2028)
Figure 51. Middle East and Africa Nucleic Acid Multiplex Assays Market Size Market Share by Application (2017-2028)
Figure 52. Middle East and Africa Nucleic Acid Multiplex Assays Market Size Share by Country (2017-2028)
Figure 53. Turkey Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Saudi Arabia Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. UAE Nucleic Acid Multiplex Assays Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. Abcam Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 57. Becton Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 58. Dickinson and Company Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 59. Merck KGaA Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 60. Agilent Technologies Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 61. Bio-Techne Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 62. Shimadzu Biotech Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 63. Thermo Fisher Scientific Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 65. Qiagen Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 66. Luminex Corporation Revenue Growth Rate in Nucleic Acid Multiplex Assays Business (2017-2022)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed